This is a news story, published by Gizmodo, that relates primarily to Ozempic news.
For more Ozempic news, you can click here:
more Ozempic newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Gizmodo, you can click here:
more news from GizmodoOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
opioid use disorder. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest opioid overdose news, reduced drug problems news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
opioidsGizmodo
•
83% Informative
Semaglutide, the active ingredient in popular GLP-1 drugs Ozempic and Wegovy , has been a valuable treatment for type 2 diabetes for nearly twenty years .
A new study shows that GLp-1s can help treat people’s addiction to opioids and alcohol.
VR Score
86
Informative language
87
Neutral language
60
Article tone
informal
Language
English
Language complexity
61
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
2
Source diversity
2
Affiliate links
no affiliate links